What the analyst said

Stifel analyst Brian Chin raised the price target on Lam Research (NASDAQ: LRCX) to $325.00 (from $300.00) while maintaining a Buy rating.

“F3Q(Mar) results exceeded ours/ cons. estimates, while guidance for F4Q(Jun) +surprised across-the-board on sequential revenue growth and margins (already surpassing Lam’s CY28/beyond target model).Though CSBG (~service/spares) growth was better-than-expected in F3Q, system revenue is the clear growth driver in F4Q (guidance implies low-mid 20s QQ growth) and calendar 2H (still expected >1H).In line with our preview, Lam increased its CY26 WFE to $140B (from $135B), on broad-based incremental strength, with added upside (possibly contingent on WFE constraints and China).

Lam was incrementally more bullish on NAND conversion spending, with the residual of $40B conversion spend pulling-into CY26-27.

Lam sees “compelling” WFE growth in CY27.Overall, we view this update as confirmation that Lam is positioned for, and operationally ready to meet, a higher ramp than most.

We raise our CY26/27 estimates, which now reflect mid-30s (from high-20s) and mid-20s YY topline growth, respectively. Maintain Buy-rating, PT to $325.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LRCX trades at $200. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $325 target is 7% below the median.

Since the note LRCX has moved −25% (from $266). 12-month window: day 198 of 365, closes on April 23, 2027.

Track record

This call✓ Target reached on June 2, 2026, 40 days after the note.

Firm track recordStifel: 83% of its 42 targets at least a year old were reached within 12 months (#6 of 26 firms). Accuracy ranking →

Earnings reactionOne of 13 notes after Lam Research’s Apr 22 results: 11 raised · 0 cut · 2 kept. See every call →

Stifel on Lam Research

Stifel price targets on Lam Research

5 calls from January 14, 2026 to July 10, 2026. The target went from $250 to $425 (+70%). The rating stayed Buy.

Stifel targetLRCX share price
  1. July 10, 2026Target raised from $325 (+31%)Buy$425
  2. April 23, 2026 This noteTarget raised from $300 (+8%)Buy$325
  3. April 13, 2026Target raised from $280 (+7%)Buy$300
  4. January 29, 2026Target raised from $250 (+12%)Buy$280
  5. January 14, 2026Earliest call shownBuy$250
Share

Other analysts on Lam Research

Lynx Equity Kept rating and price target Oct 28 $400maintained BernsteinBuy Cut price target −9%, kept rating Oct 22 $350from $385 UBSBuy Cut price target −6%, kept rating Oct 22 $400from $425 Morgan StanleyBuy Cut price target −12%, kept rating Oct 22 $339from $385 Bank of AmericaBuy Cut price target −10%, kept rating Oct 22 $345from $385
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.